Tissue-Engineering Strategies to Repair Chondral and Osteochondral Tissue in Osteoarthritis: Use of Mesenchymal Stem Cells

Current Rheumatology Reports

Volumn 16, Issue 10, 2014, Pages 1-16

  Grässel, Susanne ^a,b   Lorenz, Julia ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Animal model; Bone marrow concentrate; Cartilage; Chondral; Clinical; Collagen; Equine; Fibrin gel; Focal defect; Hyaline; Mesenchymal stem cells; Osteoarthritis; Osteochondral; Ovine; Platelet rich plasma; Porcine; Preclinical; Tissue engineering; Trauma

Indexed keywords

CALCIUM PHOSPHATE; POLYCAPROLACTONE;

ADIPOSE DERIVED STEM CELL; ARTICULAR CARTILAGE; BONE MARROW BIOPSY; BONE MARROW CONCENTRATE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL TRANSPLANTATION; CLINICAL TRIAL (TOPIC); DISEASE MODEL; EQUIDAE; HUMAN; JOINT INJURY; MESENCHYMAL STEM CELL; NONHUMAN; OSTEOARTHRITIS; PIG; REVIEW; SHEEP; TISSUE ENGINEERING; TISSUE REPAIR; MESENCHYMAL STEM CELL TRANSPLANTATION; PATHOLOGY; WOUND HEALING;

CARTILAGE, ARTICULAR; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; OSTEOARTHRITIS; WOUND HEALING;

EID: 84929502715     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-014-0452-5     Document Type: Review

References (66)

1. Pitsillides AA, Beier F. Cartilage biology in osteoarthritis-lessons from developmental biology. Nat Rev Rheumatol. 2011;7(11):654–63.
2. van den Berg WB. Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthr Cartil. 2011;19(4):338–41.
3. Dreier R. Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders. Arthritis Res Ther. 2010;12(5):216.
4. Goldring MB, Marcu KB. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther. 2009;11(3):224.
5. Mitchell N, Shepard N. Effect of patellar shaving in the rabbit. J Orthop Res. 1987;5(3):388–92.
6. Hjelle K, Solheim E, Strand T, et al. Articular cartilage defects in 1,000 knee arthroscopies. Arthroscopy. 2002;18(7):730–4.
7. Clouet J, Vinatier C, Merceron C, et al. From osteoarthritis treatments to future regenerative therapies for cartilage. Drug Discov Today. 2009;14(19–20):913–25.
8. Buckwalter JA, Brown TD. Joint injury, repair, and remodeling: roles in post-traumatic osteoarthritis. Clin Orthop Relat Res. 2004;423:7–16.
9. Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin Orthop Relat Res. 2004(427 Suppl):S6–15.
10. Steinert AF, Ghivizzani SC, Rethwilm A, et al. Major biological obstacles for persistent cell-based regeneration of articular cartilage. Arthritis Res Ther. 2007;9(3):213.
11. Steinert AF, Rackwitz L, Gilbert F, et al. Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives. Stem Cells Transl Med. 2012;1(3):237–47. This is an up to date review on clinical application of MSCs for bone, cartilage, and tendon regeneration. It discusses current clinical studies on cell-based therapies of non-unions, osteonecrosis of the hip, bone tumors, articular cartilage lesions, and ligament and tendon ruptures.
12. Frisbie DD, Cross MW, McIlwraith CW. A comparative study of articular cartilage thickness in the stifle of animal species used in human pre-clinical studies compared to articular cartilage thickness in the human knee. Vet Comp Orthop Traumatol VCOT. 2006;19(3):142–6.
13. Bouwmeester PS, Kuijer R, Homminga GN, et al. A retrospective analysis of two independent prospective cartilage repair studies: autogenous perichondrial grafting versus subchondral drilling 10 years post-surgery. J Orthop Res Off Publ Orthop Res Soc. 2002;20(2):267–73.
14. Ahern BJ, Parvizi J, Boston R, et al. Preclinical animal models in single site cartilage defect testing: a systematic review. Osteoarthr Cartil OARS Osteoarthr Res Soc. 2009;17(6):705–13.
15. Mrugala D, Bony C, Neves N, et al. Phenotypic and functional characterisation of ovine mesenchymal stem cells: application to a cartilage defect model. Ann Rheum Dis. 2008;67(3):288–95.
16. Zscharnack M, Hepp P, Richter R, et al. Repair of chronic osteochondral defects using predifferentiated mesenchymal stem cells in an ovine model. Am J Sports Med. 2010;38(9):1857–69.
17. Marquass B, Schulz R, Hepp P, et al. Matrix-associated implantation of predifferentiated mesenchymal stem cells versus articular chondrocytes: in vivo results of cartilage repair after 1 year. Am J Sports Med. 2011;39(7):1401–12. This pre-clinical study compares the regenerative capacities of pre-differentiated BMSCs versus chondrocytes implanted into osteochondral lesions in a sheep model. BMSC performance was superior to chondrocytes with respect to O’Driscoll and ICRS scores until 1-year follow up.
18. Marquass B, Somerson JS, Hepp P, et al. A novel MSC-seeded triphasic construct for the repair of osteochondral defects. J Orthop Res. 2010;28(12):1586–99.
19. Guo X, Wang C, Zhang Y, et al. Repair of large articular cartilage defects with implants of autologous mesenchymal stem cells seeded into beta-tricalcium phosphate in a sheep model. Tissue Eng. 2004;10(11–12):1818–29.
20. Frosch KH, Drengk A, Krause P, et al. Stem cell-coated titanium implants for the partial joint resurfacing of the knee. Biomaterials. 2006;27(12):2542–9.
21. Steck E, Fischer J, Lorenz H, et al. Mesenchymal stem cell differentiation in an experimental cartilage defect: restriction of hypertrophy to bone-close neocartilage. Stem Cells Dev. 2009;18(7):969–78.
22. Zhou G, Liu W, Cui L, et al. Repair of porcine articular osteochondral defects in non-weightbearing areas with autologous bone marrow stromal cells. Tissue Eng. 2006;12(11):3209–21.
23. Ho ST, Hutmacher DW, Ekaputra AK, et al. The evaluation of a biphasic osteochondral implant coupled with an electrospun membrane in a large animal model. Tissue Eng A. 2010;16(4):1123–41.
24. Chang CH, Kuo TF, Lin FH, et al. Tissue engineering-based cartilage repair with mesenchymal stem cells in a porcine model. J Orthop Res Off Publ Orthop Res Soc. 2011;29(12):1874–80. This study compared repair capacity of pre-differentiated with undifferentiated BMSCs implanted in osteochondral defects in minipigs. The quality of the repair tissue was inferior and no difference between groups was observed.
25. Wilke MM, Nydam DV, Nixon AJ. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res Off Publ Orthop Res Soc. 2007;25(7):913–25.
26. Seo JP, Tanabe T, Tsuzuki N, et al. Effects of bilayer gelatin/beta-tricalcium phosphate sponges loaded with mesenchymal stem cells, chondrocytes, bone morphogenetic protein-2, and platelet rich plasma on osteochondral defects of the talus in horses. Res Vet Sci. 2013;95(3):1210–6. This study analyzed repair the capacity of BMSCs loaded onto biphasic sponge scaffolds and implanted in osteochondral defects in horses. After 4 months, the test group had significantly higher radiographic, QCT, macroscopic, and histological scores than the control group with biphasic sponge without cells and growth factor.
27. Lu Y, Hayashi K, Hecht P, et al. The effect of monopolar radiofrequency energy on partial-thickness defects of articular cartilage. Arthrosc J Arthrosc Relat Surg Off Publ Arthrosc Assoc N Am Int Arthrosc Assoc. 2000;16(5):527–36.
28. O’Driscoll SW, Marx RG, Beaton DE, et al. Validation of a simple histological-histochemical cartilage scoring system. Tissue Eng. 2001;7(3):313–20.
29. Mainil-Varlet P, Aigner T, Brittberg M, et al. Histological assessment of cartilage repair: a report by the Histology Endpoint Committee of the International Cartilage Repair Society (ICRS). J Bone Joint Surg Am Vol. 2003;85-A Suppl 2:45–57.
30. Chiang H, Kuo TF, Tsai CC, et al. Repair of porcine articular cartilage defect with autologous chondrocyte transplantation. J Orthop Res Off Publ Orthop Res Soc. 2005;23(3):584–93.
31. Hembry RM, Dyce J, Driesang I, et al. Immunolocalization of matrix metalloproteinases in partial-thickness defects in pig articular cartilage. A preliminary report. J Bone Joint Surg Am Vol. 2001;83-A(6):826–38.
32. Pineda S, Pollack A, Stevenson S, et al. A semiquantitative scale for histologic grading of articular cartilage repair. Acta Anat. 1992;143(4):335–40.
33. Bryant SJ, Anseth KS. The effects of scaffold thickness on tissue engineered cartilage in photocrosslinked poly(ethylene oxide) hydrogels. Biomaterials. 2001;22(6):619–26.
34. Noth U, Steinert AF, Tuan RS. Technology insight: adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol. 2008;4(7):371–80.
35. Grassel S, Anders S. Cell-based therapy options for osteochondral defects. Autologous mesenchymal stem cells compared to autologous chondrocytes. Orthopade. 2012;41(5):415–28. quiz 429–430.
36. Steinwachs MR, Guggi T, Kreuz PC. Marrow stimulation techniques. Injury. 2008;39 Suppl 1:S26–31.
37. Richter W. Mesenchymal stem cells and cartilage in situ regeneration. J Intern Med. 2009;266(4):390–405.
38. Blevins FT, Steadman JR, Rodrigo JJ, et al. Treatment of articular cartilage defects in athletes: an analysis of functional outcome and lesion appearance. Orthopedics. 1998;21(7):761–7. discussion 767–768.
39. Steadman JR, Briggs KK, Rodrigo JJ, et al. Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy. 2003;19(5):477–84.
40. Richter W. Cell-based cartilage repair: illusion or solution for osteoarthritis. Curr Opin Rheumatol. 2007;19(5):451–6.
41. Filardo G, Madry H, Jelic M, et al. Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc Off J ESSKA. 2013;21(8):1717–29. This is an up-to-date systematic review on clinical studies using MSC treatment strategies for cartilage defect regeneration.
42. Gigante A, Calcagno S, Cecconi S, et al. Use of collagen scaffold and autologous bone marrow concentrate as a one-step cartilage repair in the knee: histological results of second-look biopsies at 1 year follow-up. Int J Immunopathol Pharmacol. 2011;24(1 Suppl 2):69–72.
43. Gigante A, Cecconi S, Calcagno S, et al. Arthroscopic knee cartilage repair with covered microfracture and bone marrow concentrate. Arthrosc Tech. 2012;1(2):e175–80.
44. Enea D, Cecconi S, Calcagno S, et al. Single-stage cartilage repair in the knee with microfracture covered with a resorbable polymer-based matrix and autologous bone marrow concentrate. Knee. 2013;20(6):562–9. This case series describes treatment of trauma-induced focal condylar knee lesions with a combination of MFX, biomaterial, and bone marrow concentrate. They report significant improvement of several clinical scores and complete defect filling.
45. Giannini S, Buda R, Vannini F, et al. One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res. 2009;467(12):3307–20.
46. Skowronski J, Skowronski R, Rutka M. Large cartilage lesions of the knee treated with bone marrow concentrate and collagen membrane-results. Ortop Traumatol Rehabil. 2013;15(1):69–76.
47. Giannini S, Buda R, Cavallo M, et al. Cartilage repair evolution in post-traumatic osteochondral lesions of the talus: from open field autologous chondrocyte to bone-marrow-derived cells transplantation. Injury. 2010;41(11):1196–203.
48. Wakitani S, Mitsuoka T, Nakamura N, et al. Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant. 2004;13(5):595–600.
49. Kuroda R, Ishida K, Matsumoto T, et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthr Cartil OARS Osteoarthr Res Soc. 2007;15(2):226–31.
50. Wakitani S, Nawata M, Tensho K, et al. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med. 2007;1(1):74–9.
51. Haleem AM, Singergy AA, Sabry D, et al. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage. 2010;1(4):253–61.
52. Nejadnik H, Hui JH, Feng Choong EP, et al. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38(6):1110–6.
53. Varma HS, Dadarya B, Vidyarthi A. The new avenues in the management of osteo-arthritis of knee–stem cells. J Indian Med Assoc. 2010;108(9):583–5.
54. Kim JD, Lee GW, Jung GH, et al. Clinical outcome of autologous bone marrow aspirates concentrate (BMAC) injection in degenerative arthritis of the knee. Eur J Orthop Surg Traumatol Orthop Traumatol. 2014. This group combined intraarticular injection of autologous BMC with adipose tissue (BMAC) into knees of 41 patients with radiographically assessed OA. BMAC injection significantly improved both knee pain and function in all patients.
55. Centeno CJ, Busse D, Kisiday J, et al. Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician. 2008;11(3):343–53.
56. Centeno CJ, Schultz JR, Cheever M, et al. Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2010;5(1):81–93.
57. Centeno CJ, Schultz JR, Cheever M, et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2011;6(4):368–78.
58. Emadedin M, Aghdami N, Taghiyar L, et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med. 2012;15(7):422–8. This is the first group who injected expanded BMSCs into knee joints of OA patients.
59. Davatchi F, Abdollahi BS, Mohyeddin M, et al. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis. 2011;14(2):211–5.
60. Pak J. Regeneration of human bones in hip osteonecrosis and human cartilage in knee osteoarthritis with autologous adipose-tissue-derived stem cells: a case series. J Med Case Rep. 2011;5:296. This is the first group who injected concentrated (not expanded) ADSCs in combination with PRP into knee joints of OA patients.
61. Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee. 2012;19(6):902–7.
62. Koh YG, Jo SB, Kwon OR, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy. 2013;29(4):748–55.
63. Koh YG, Choi YJ, Kwon SK, et al. Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc Off J ESSKA. 2013.
64. Wakitani S, Imoto K, Yamamoto T, et al. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil. 2002;10(3):199–206.
65. Koh YG, Choi YJ, Kwon OR, et al. Second-look arthroscopic evaluation of cartilage lesions after mesenchymal stem cell implantation in osteoarthritic knees. Am J Sports Med. 2014. This study implanted ASDCs without expansion into isolated full-thickness cartilage lesions of OA patients.
66. Wong KL, Lee KB, Tai BC, et al. Injectable cultured bone marrow-derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthroscopy. 2013;29(12):2020–8.